CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention Successful catheter ablation of electrical storm after myocardial infarction Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography
|<<... 50 51 52 53 54 55 56 ...>>|

Clinical Trial2020 Sep 7;41(34):3239-3252.

JOURNAL：Eur Heart J. Article Link

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction

TJ Ford, D Corcoran, S Padmanabhan et al. Keywords: coronary microvascular dysfunction; endothelin-1; microvascular angina; precision medicine; single-nucleotide polymorphism; stable angina pectoris

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top